Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

DCTH

Delcath Systems (DCTH)

Delcath Systems Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DCTH
DateTimeSourceHeadlineSymbolCompany
31/08/200920:30PR Newswire (US)FDA Grants Delcath Orphan-Drug Designation for DoxorubicinNASDAQ:DCTH
25/08/200920:30PR Newswire (US)Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%NASDAQ:DCTH
11/08/200905:00PR Newswire (US)Delcath Systems to Present at Canaccord Adams 29th Annual Global Growth ConferenceNASDAQ:DCTH
28/07/200908:16PR Newswire (US)Delcath Systems Provides Update on ProgressNASDAQ:DCTH
28/07/200906:05PR Newswire (US)Delcath Systems Provides Update on ProgressNASDAQ:DCTH
14/07/200920:30PR Newswire (US)Delcath Systems to Host July 27th Conference Call to Update Investors on Recent ProgressNASDAQ:DCTH
06/07/200922:11PR Newswire (US)Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.NASDAQ:DCTH
15/06/200922:00PR Newswire (US)Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) IndexNASDAQ:DCTH
10/06/200922:00PR Newswire (US)Delcath Enters Agreement to Sell 869,565 UnitsNASDAQ:DCTH
08/06/200922:00PR Newswire (US)Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent AccrualNASDAQ:DCTH
02/06/200922:00PR Newswire (US)Delcath Systems Granted Third Orphan Drug DesignationNASDAQ:DCTH
08/05/200900:43PR Newswire (US)Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on MelanomaNASDAQ:DCTH
09/04/200923:04PR Newswire (US)Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)NASDAQ:DCTH
20/02/200900:24PR Newswire (US)Dr. James F. Pingpank to Present at Leading Regional Therapies ConferenceNASDAQ:DCTH
21/01/200905:44PR Newswire (US)Delcath Systems to Host Quarterly Update Conference CallNASDAQ:DCTH
31/12/200802:26PR Newswire (US)Delcath Systems to Host Quarterly Update Conference CallNASDAQ:DCTH
18/12/200800:00PR Newswire (US)Delcath Adds Dr. Pamela R. Contag to Its Board of DirectorsNASDAQ:DCTH
12/12/200800:00PR Newswire (US)Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway PointNASDAQ:DCTH
10/12/200800:00PR Newswire (US)Delcath Adds Senior Pharmaceutical Professional to Its Board of DirectorsNASDAQ:DCTH
05/12/200800:00PR Newswire (US)Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of DirectorsNASDAQ:DCTH
03/12/200800:00PR Newswire (US)Delcath Adds University of Pittsburgh Medical Center to Phase III TrialNASDAQ:DCTH
19/11/200800:00PR Newswire (US)Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular MelanomaNASDAQ:DCTH
 Showing the most relevant articles for your search:NASDAQ:DCTH